Effects of Functional Postural Control Training on Functional Performance in People With Parkinson's Disease With Freezing of Gait

Sponsor
National Yang Ming University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05958355
Collaborator
(none)
20
1
2
10
2

Study Details

Study Description

Brief Summary

The purpose of this single-blinded, randomized controlled study aims to establish the effects of functional postural control training on functional performance and FOG in PD individuals with FoG as compared with treadmill training.

Condition or Disease Intervention/Treatment Phase
  • Other: Functional postural control training
  • Other: Treadmill training
N/A

Detailed Description

Background and purpose: Freezing of gait (FoG), is a common sign in patients with Parkinson's disease (PD), especially at the advanced stage. Advanced functional activities, such as dual task walking, turning, or crossing a door often induce the FOG. FoG is a complex phenomenon which pathophysiology is currently unknown. However, previous studies have found that postural instability may be a risk factor for FoG. In addition, previous studies have suggested the interactions between FoG and postural instability. Treadmill training has been shown to be relatively more effective to improve FoG than other interventions. On the other hand, postural control training was demonstrated to improve the severity of FoG and postural control in freezers. However, no study has investigated the effectiveness of functional postural control training on functional performance and FOG. Therefore, this study aims to establish the effects of functional postural control training on functional performance and FOG in PD individuals with FoG as compared with treadmill training.

Methods: This study is a single-blinded randomized controlled trial. Twenty PD people with FoG will be recruited and randomized to the experimental and control group. The experimental group will receive functional postural control training, and the control group will receive treadmill training. Each intervention is 30 minutes/ session, 3 sessions/ weeks, for 4 weeks. The primary outcome is functional performance, which will measure the walking speed, cadence, and step length in the four conditions, including (1) Time up and go test, (2) Dual task Time up and go test, (3) 360º turning in place, and (4) Walking through the door. The secondary outcome is the severity of FoG which is assessed by the New Freezing of Gait Questionnaire (NFOGQ). All outcomes will be assessed before and after the training program. Demographic data at baseline will be analyzed by using Chi-square test or independent T-test. Two-way repeated ANOVA will be performed to analyze the primary and secondary outcomes. The significance level is set at p<0.05.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Functional Postural Control Training on Functional Performance in People With Parkinson's Disease With Freezing of Gait
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Jun 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Functional postural control training

The training includes (1) Maintaining a stationary posture in a standing position for a total of 10 minutes, (2) Posture control training involving unilateral lower limb stepping movements for a total of 10 minutes, and (3) Advanced walking task training, including sudden stops, turns, ball raises, and obstacle crossing during walking, for a total of 10 minutes.

Other: Functional postural control training
All participants will receive functional postural control training for 30 minutes/ session, 3 sessions/ weeks, for 4 weeks (a total of 12 training sessions).

Active Comparator: Treadmill training

The subjects in the control group performed a 30-minute walking session on a treadmill at a self-selected speed.

Other: Treadmill training
All participants will receive treadmill training for 30 minutes/ session, 3 sessions/ weeks, for 4 weeks (a total of 12 training sessions).

Outcome Measures

Primary Outcome Measures

  1. Functional performance-Time up and go test-speed(m/s) [Change from baseline time up and go test walking speed and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate walking speed during the Time Up and Go test.

  2. Functional performance-Time up and go test-cadence (steps/ min) [Change from baseline time up and go test cadence and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate cadence during the Time Up and Go test.

  3. Functional performance-Time up and go test-step length (m) [Change from baseline time up and go test step length and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate step length during the Time Up and Go test.

  4. Functional performance-dual task Time up and go test-speed(m/s) [Change from baseline dual task time up and go test walking speed and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate walking speed during the dual task Time up and go test.

  5. Functional performance-dual task Time up and go test-cadence (steps/ min) [Change from baseline dual task time up and go test cadence and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate cadence during the dual task Time up and go test.

  6. Functional performance-dual task Time up and go test-step length (m) [Change from baseline dual task time up and go test step length and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate step length during the dual task Time up and go test.

  7. Functional performance-360º turning in place-speed(m/s) [Change from baseline 360º turning in place speed and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate speed during the 360º turning in place test.

  8. Functional performance-360º turning in place-cadence (steps/ min) [Change from baseline 360º turning in place cadence and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate cadence during the 360º turning in place test.

  9. Functional performance-360º turning in place-step length (m) [Change from baseline 360º turning in place step length and up to 4 weeks (pre- and post-test)]

    Using GaitUp system to evaluate step length during the 360º turning in place test.

  10. Functional performance-Walking through the door-speed(m/s) [Change from baseline walking through the door speed and up to 4 weeks (pre- and post-test)]

    Using GAITRite® system to evaluate walking speed during walks through the door.

  11. Functional performance-Walking through the door-cadence (steps/ min) [Change from baseline walking through the door cadence and up to 4 weeks (pre- and post-test)]

    Using GAITRite® system to evaluate cadence during walks through the door.

  12. Functional performance-Walking through the door-step length (m) [Change from baseline walking through the door step length and up to 4 weeks (pre- and post-test)]

    Using GAITRite® system to evaluate step length during walks through the door.

Secondary Outcome Measures

  1. New Freezing of Gait Questionnaire (NFOGQ) [Change from baseline New Freezing of Gait Questionnaire and up to 4 weeks (pre- and post-test)]

    Use the New Freezing of Gait Questionnaire (NFOGQ)-Chinese version to assess the severity of freezing of gait. The score ranged from 0 to 29. Higher scores show increased severity in freezing of gait.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hoehn and Yahr stage 2~4

  • Age between 50 to 80 years

  • New Freezing of Gait Questionnaire score > 1

  • Able to walk independently for at least 10 meters

  • MMSE score ≥24

Exclusion Criteria:
  • Neurological diseases other than PD

  • Any cardiovascular, pulmonary, or orthopedic conditions that would impact participation in the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Yang Ming Chiao Tung University Taipei Taiwan 112

Sponsors and Collaborators

  • National Yang Ming University

Investigators

  • Principal Investigator: Ray-Yau Wang, PhD, National Yang Ming Chiao Tung University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ray-Yau Wang, Professor, National Yang Ming University
ClinicalTrials.gov Identifier:
NCT05958355
Other Study ID Numbers:
  • NYCU112071AF
First Posted:
Jul 24, 2023
Last Update Posted:
Jul 28, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ray-Yau Wang, Professor, National Yang Ming University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2023